> 31 Neutropenia febril en pacientes con tumor de órgano sólido BIBLIOGRAFÍA RECOMENDADA - Aguado JM, Cruz JJ, Virizuela JA, Aguilar M, Carmona A, Cassinello J, et al. Management of Infection and Febrile Neutropenia in Patients with Solid Cancer. Enferm Infecc Microbiol Clin. 2017 Aug-Sep;35(7):451-60. - Carmona-Bayonas A, Jiménez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, et al. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clin Transl Oncol. 2019 Jan;21(1):75-86. - Gudiol C, Aguilar-Guisado M, Azanza JR, Candel FJ, Cantón R, Carratalà J, et al. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. Enferm Infecc Microbiol Clin. 2020 Apr;38(4):174-81. - Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. ESMO Guidelines Committee. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.Ann Oncol. 2016 Sep;27(Suppl 5): v111-8. - Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, et al. Practice Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update Guideline. J Clin Oncol. 2015 Oct 1;33(28):3199-212. - Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Update. J Clin Oncol. 2018 May;10;36(14):1443-53.
RkJQdWJsaXNoZXIy OTI4NTYw